PATENT CLAIM ANALYSIS

Application Number: 16194430
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "04400A"]

Abstract:
A method of treating a lipid-related disorder in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polynucleotide agent which is substantially complementary to a nucleotide sequence of human miR-132, thereby treating the lipid related disorder in the subject.

Claim (Index 2):
The method of  claim 1 , wherein said polynucleotide comprises the nucleic acid sequence as set forth in SEQ ID NO: 8 or at least 15 consecutive bases thereof.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 98.0
- Lexical Diversity: 1.51429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15511648', '14701150', '15293728', '13979428', '14342867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7859457490986881
- 35 USC 102 Novelty (BERT): 0.6693216918075285
- Combined Prediction Score: 0.7742833433695722
- Mean Citation Score: 390.252188
- Max Citation Score: 652.5515
- Similarity Product: 648.0747517393231

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test